Multi-omics analysis has emerged as a powerful approach in translational medicine, integrating diverse molecular data to ...

In today's fast-paced and ever-evolving landscape of clinical trials, the ability to efficiently analyze and visualize data has become paramount. The vast amounts of data generated from these trials ...

If data represents the next gold rush for health care, a vast treasure trove of it slips away every day. The increased enthusiasm for AI has led to significant investments in novel solutions for ...

AI-driven discovery, EHR-based real-world evidence, and synthetic patient modeling are rapidly reshaping drug repurposing, reducing development timelines, expanding therapeutic applications, and ...

Increasing clinical trial participant representation in clinical research is critical to developing new medicines that are safe and effective for patients in need. However, historical clinical ...

Words reflecting diversity language have appeared less frequently in grants awarded by the National Institutes of Health (NIH) since the 2024 US presidential election, with a 25% relative decrease ...

Cytogenetic risk doesn't seem to explain the disparity in mortality of Black vs White patients, a study across 10 clinical ...

Historically, medical research has been male-dominated in terms of subjects as well as researchers, even though women make up half of the world’s population. As a result of this gender bias, insights ...